# Danggui Niantong granules in the treatment of rheumatoid arthritis - a mechanistic approach using ceRNA networks

**Authors:** Yisi Cai, Yanyan Song, Xiaoling Zeng, Gang Liu, Lixia Yuan

PMC · DOI: 10.3389/fphar.2026.1718584 · Frontiers in Pharmacology · 2026-02-06

## TL;DR

This study explores how Danggui Niantong granules treat rheumatoid arthritis by analyzing RNA networks and cell behavior.

## Contribution

The study introduces a novel ceRNA network-based approach to elucidate the molecular mechanisms of DGNTG in rheumatoid arthritis.

## Key findings

- DGNTG inhibits proliferation, migration, and invasion of MH7A cells.
- A ceRNA network was constructed using transcriptomic data from DGNTG-treated cells.
- DGNTG's effects may involve multiple pathways identified through bioinformatics analysis.

## Abstract

Danggui Niantong granules (DGNTG), a traditional Chinese medicine, serve as an effective therapeutic agent for the treatment of rheumatoid arthritis (RA). However, the comprehensive molecular mechanisms of DGNTG in RA remain unclear. Increasing evidence highlights the significant role of competing endogenous RNAs (ceRNA) in diagnosing and treating various diseases.

The study aims to explore the molecular mechanism of DGNTG in the treatment of RA through the ceRNA network.

The MH7A cells were divided into control group and DGNTG group (2 and 4 mg/mL).The proliferation, migration and invasion ability of MH7A were accessed using MTT assay, cloning formation, wound-healing assay transwell assay and Western blotting. Subsequently, ceRNA microarray analyses were performed and a circRNA-miRNA-mRNA ternary transcription network was established. The data were validated through qPCR.

DGNTG inhibited proliferation, suppressed migration and invasion in MH7A (P < 0.05, 0.01 or  0.001), with the most pronounced effects observed in the DGNTG (4 mg/mL) group. Subsequently, we identified 301 differentially expressed mRNAs and 507 differentially expressed circRNAs (FC ≤ 0.5 or ≥2, P < 0.05). Bioinformatics analyses indicated that DGNTG may exert therapeutic effects through multiple pathways. Furthermore, we constructed a circRNA-miRNA-mRNA network and conducted additional bioinformatics analysis on this network. In addition, we developed a representative ceRNA network and analyzed the correlations among its components.

This study presents evidence that DGNTG exerts anti-RA effects through the inhibition of synoviocyte proliferation, migration and invasion. Additionally, It provided a valuable resource for elucidating the mechanism of action of DGNTG by constructing a competing endogenous RNA network based on transcriptomic data obtained from DGNTG-treated MH7A cells.

## Linked entities

- **Diseases:** rheumatoid arthritis (MONDO:0008383)

## Full-text entities

- **Genes:** SLC6A9 (solute carrier family 6 member 9) [NCBI Gene 6536] {aka GCENSG, GLYT1, IS6}, MIR6089 (microRNA 6089) [NCBI Gene 102464837] {aka MIR6089-1, MIR6089-2, hsa-mir-6089-1, hsa-mir-6089-2}, MIR1253 (microRNA 1253) [NCBI Gene 100302208] {aka MIRN1253, hsa-mir-1253}, RGL2 (ral guanine nucleotide dissociation stimulator like 2) [NCBI Gene 5863] {aka HKE1.5, KE1.5, RAB2L}, SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446] {aka SGK}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, FOXO6 (forkhead box O6) [NCBI Gene 100132074], MIR548C (microRNA 548c) [NCBI Gene 693129] {aka MIRN548C}, RTEL1 (regulator of telomere elongation helicase 1) [NCBI Gene 51750] {aka C20orf41, DKCA4, DKCB5, NHL, PFBMFT3, RTEL}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CSNK2A1 (casein kinase 2 alpha 1) [NCBI Gene 1457] {aka CK2A1, CKII, Cka1, Cka2, OCNDS}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, GMPPB (GDP-mannose pyrophosphorylase B) [NCBI Gene 29925] {aka LGMDR19, MDDGA14, MDDGB14, MDDGC14}, MIR1258 (microRNA 1258) [NCBI Gene 100302172] {aka MIRN1258, hsa-mir-1258, mir-1258}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, B4GALT5 (beta-1,4-galactosyltransferase 5) [NCBI Gene 9334] {aka B4Gal-T5, BETA4-GALT-IV, beta4Gal-T5, beta4GalT-V, gt-V}, ZBTB41 (zinc finger and BTB domain containing 41) [NCBI Gene 360023] {aka FRBZ1, ZNF924}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) [NCBI Gene 3955] {aka SCDO3}, MIR1208 (microRNA 1208) [NCBI Gene 100302281] {aka MIRN1208, hsa-mir-1208}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, CEPT1 (choline/ethanolamine phosphotransferase 1) [NCBI Gene 10390], Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, MT1H (metallothionein 1H) [NCBI Gene 4496] {aka MT-0, MT-1H, MT-IH, MT1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, ASAH1 (N-acylsphingosine amidohydrolase 1) [NCBI Gene 427] {aka AC, ACDase, ASAH, PHP, PHP32, SMAPME}, MIR548M (microRNA 548m) [NCBI Gene 100313772] {aka MIRN548M}, FLNA (filamin A) [NCBI Gene 2316] {aka ABP-280, ABPX, CSBS, CVD1, FGS2, FLN}, TMEM105 (TMEM105 long non-coding RNA) [NCBI Gene 284186], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, POLR3G (RNA polymerase III subunit G) [NCBI Gene 10622] {aka C31, RPC32, RPC7}, MAPK4 (mitogen-activated protein kinase 4) [NCBI Gene 5596] {aka ERK-4, ERK4, PRKM4, p63-MAPK, p63MAPK}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, HBP1 (HMG-box transcription factor 1) [NCBI Gene 26959], RPL5 (ribosomal protein L5) [NCBI Gene 6125] {aka L5, MSTP030, PPP1R135, uL18}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, LDHA (lactate dehydrogenase A) [NCBI Gene 3939] {aka GSD11, HEL-S-133P, LDHM, PIG19}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** hepatocellular carcinoma (MESH:D006528), destruction (MESH:D008105), hyperplasia (MESH:D006965), DGNTG (MESH:C562873), glioblastoma (MESH:D005909), infections (MESH:D007239), bone destruction (MESH:D001847), joint (MESH:D007592), arthritis (MESH:D001168), RA (MESH:D001172), liver metastasis (MESH:D009362), stiffness (MESH:C566112), joint deformities (MESH:D016916), colorectal cancer (MESH:D015179), non-small cell lung cancer (MESH:D002289), articular cartilage (MESH:D002357), hypoxia (MESH:D000860), autoimmune disease (MESH:D001327), multiple myeloma (MESH:D009101), cancer (MESH:D009369), swelling (MESH:D004487), osteosarcoma (MESH:D012516), inflammation (MESH:D007249), prostate cancer (MESH:D011471), pain (MESH:D010146)
- **Chemicals:** PBS (MESH:D007854), polyvinylidene fluoride (MESH:C024865), DMSO (MESH:D004121), baicalin (MESH:C038044), ROS (MESH:D017382), CO2 (MESH:D002245), MTT (MESH:C070243), CBP61649 (-), Crystal Violet (MESH:D005840), penicillin (MESH:D010406), SDS (MESH:D012967), ethanol (MESH:D000431), glycine (MESH:D005998), streptomycin (MESH:D013307), methanol (MESH:D000432)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** MH7A — Homo sapiens (Human), Transformed cell line (CVCL_0427), CVCL_0427 — Homo sapiens (Human), Finite cell line (CVCL_2F12)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920595/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920595/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920595/full.md

---
Source: https://tomesphere.com/paper/PMC12920595